Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Merck | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Merck

Margie McGlynn, president of Merck Vaccines and Infectious Diseases, has resigned effective November 1st.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Margie McGlynn, president of Merck Vaccines and Infectious Diseases, has resigned effective November 1st. Amy Rose, a spokeswoman for the company, commented, “She has professional and personal aspirations she’d like to pursue.” A replacement has not yet been named.

Ms. McGlynn oversaw the launch of Gardasil cervical cancer vaccine, Rotateq rotavirus vaccine and Zostavax shingles vaccine, among other products. She spent 26 years with the company and previously helped run U.S. commercial operations.

Merck is expected to complete its $41 billion acquisition of Schering-Plough by the end of the year. According to Ms. Rose, the company will announce the members of the executive committee of the combined Merck/Schering-Plough, and senior management, as the close of the merger nears.

Sign up today for Contracting & Outsourcing 2009!

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters